Knott David M Jr Viridian Therapeutics, Inc.\De Transaction History
Knott David M Jr
- $173 Million
- Q4 2024
A detailed history of Knott David M Jr transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Knott David M Jr holds 25,000 shares of VRDN stock, worth $425,500. This represents 0.28% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$425,500% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding VRDN
# of Institutions
193Shares Held
78.5MCall Options Held
575KPut Options Held
441K-
Black Rock Inc. New York, NY4.77MShares$81.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.6MShares$78.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.52MShares$77 Million3.82% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$66.1 Million9.15% of portfolio
-
State Street Corp Boston, MA3.52MShares$60 Million0.0% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $679M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...